NCT02655146 is a Phase 4 clinical trial of triptorelin 0.1 in Infertility, sponsored by Chong Qing Reproducive and Genetic Institute.

Who is sponsoring NCT02655146?

NCT02655146 is sponsored by Chong Qing Reproducive and Genetic Institute.

What drugs are being tested in NCT02655146?

Interventions in NCT02655146: triptorelin 0.1, E2, Progesterone, triptorelin 3.75mg.

What condition does NCT02655146 study?

NCT02655146 studies Infertility.

Is NCT02655146 still recruiting?

NCT02655146 is currently status unknown. Last updated 12 January 2016.

Last reviewed 2016-01-12 · How we verify

NCT02655146

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Implantation in Frozen Embryo Transfer

Status unknown Phase 4 Last updated 12 January 2016

What this trial tests

Phase 4 trial testing triptorelin 0.1 in Infertility in 700 participants. Status unknown.

Timeline

1 December 2015

Primary endpoint
1 December 2016

1 March 2017

Quick facts

Lead sponsor	Chong Qing Reproducive and Genetic Institute
Phase	Phase 4
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	700
Start date	1 December 2015
Primary completion	1 December 2016
Estimated completion	1 March 2017
Sites	1 location across China

Drugs / interventions tested

triptorelin 0.1 — full drug profile →
E2 — full drug profile →
Progesterone (Progesterone plus HCG) — full drug profile →
triptorelin 3.75mg

Conditions studied

Infertility — all drugs for Infertility →

Sponsor

Chong Qing Reproducive and Genetic Institute

Who can join

Adults 20 to 37, female only, with Infertility. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

implantation rate
Time frame: 5 weeks

Sponsor's own description

The aim of the present prospective randomized controlled study was to determine the effects of GnRHa add up to routine luteal phase support on frozen embryo implantation in frozen embryo transfer (FET).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Infertility

Currently open trials in the same condition.

NCT07074015 — IntelliWell: An AI-Assisted Imaging Platform for Detection and Location of Ultra-Rare Testicular Sperm in Surgical Speci · NA · recruiting
NCT07358468 — Impact Of FET Preparation Protocol On Endometrial Peristalsis: A Prospective Cohort Study · recruiting
NCT07340827 — A Study to Compare the Efficacy and Safety of Follitropin Alfa/Lutropin Alfa Versus hMG in Japanese Participants With LH · Phase 3 · recruiting
NCT07369362 — To Investigate if the Harvester® Improves Sperm Motility and Blastocyst Utilization (the Percent of Fertilized Eggs That · NA · active not recruiting
NCT07153367 — Using a Fixed Dosage of Follitropin Delta for Ovarian Stimulation for Intrauterine Insemination: Rekovelle for Intrauter · Phase 2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02655146 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Chong Qing Reproducive and Genetic Institute
Last refreshed: 12 January 2016

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02655146.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing